Search
iBio Inc
IBIOAdd to Watchlist
0.920USD
-0.090-8.91%
Close 10-08 16:00（ET）
45.71MMarket Cap
LossP/E TTM
iBio Inc (IBIO) Stock Price Target & Forecast
Analyst Rating
Based on 8 analysts giving stock ratings to iBio Inc in the past month.
Buy
2 Strong Buy
6 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
5.689USD+405.68%
IBIO Analyst Recommendation Trends
In the current month, IBIO has received 6 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. IBIO average Analyst price target in the last month is 5.689.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2
2
2
2
2
2
2
2
6
6
4
4
3
3
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8
8
6
6
5
5
4
4
IBIO Analyst Rating for Peer Comparison
Updated: Oct 8, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
0
0
27
argenx SE
ARGX
10
13
3
0
0
26
Insmed Inc
INSM
7
18
0
0
0
25
Ionis Pharmaceuticals Inc
IONS
6
14
5
0
0
25
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
Revolution Medicines Inc
RVMD
8
14
1
0
0
23
Tempus AI Inc
TEM
4
7
11
0
1
23
IQVIA Holdings Inc
IQV
8
11
3
0
0
22
Cytokinetics Inc
CYTK
4
16
2
0
0
22
Biontech SE
BNTX
4
13
5
0
0
22
Financial Forecasting
Based on analysts' estimates, IBIO EPS is projected to reach -0.072 in FY2027Q1, following reported EPS of -0.073 in FY2026Q4. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q2
FY2026Q3
FY2026Q4
FY2027Q1
FY2027Q2
Forecast
-0.08
-0.06
-0.06
-0.07
-0.09
Actual
-0.30
-0.06
-0.07
--
--
Surprise
-262.72%
-3.13%
-14.40%
--
--
FAQs
What is iBio Inc's expected revenue for the next quarter?
iBio Inc's expected revenue is 20.00K.
What is iBio Inc's price target?
Analysts forecast that iBio Inc's price target is USD 5.69, with the highest forecast at USD 7.00 and the lowest forecast at USD 4.20.
How have iBio IncIBIO's recent earnings per share performed?
The market expectation was USD -0.07, while iBio IncIBIO's earnings per share (EPS) for the previous quarter was USD -0.06. EPS for the next quarter is expected at USD -0.07.
What is the analyst rating for iBio Inc?
Based on the ratings of iBio Inc's stock from 8 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.